BioMed Research International

Genomic Instability, Inflammation and Cancer


Publishing date
25 May 2012
Status
Published
Submission deadline
30 Dec 2011

1Department of Histology and Embryology, Medical School, University of Athens, Athens, Greece

2ICREA, Institute for Research in Biomedicine, Barcelona, Spain

3Institute of Cancer Biology and Centre for Genotoxic Stress Research, Danish Cancer Society, Copenhagen, Denmark

4Molecular & Cellular Biology Laboratory, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece


Genomic Instability, Inflammation and Cancer

Description

Genomic instability is an evolving hallmark of cancer. In hereditary cancers, it is an important event driving tumor formation. In sporadic carcinomas, large-scale analyses demonstrate that aberrations of growth-regulating genes may lead to genomic instability that in turn fuels cancer progression. Recent studies support that several inflammatory mediators induce genomic instability providing clues for the increased cancer risk in chronic inflammatory conditions. Data from humans and mouse models suggest that the immune system has both a bright and a dark side in carcinogenesis. Clarifying which immune functions are culprits for tumor promotion and which participate in immunosurveillance is vital in order to exploit this knowledge therapeutically.

We invite authors to provide original research and review articles that highlight the link between inflammation and genomic instability in both humans and rodents. We are particularly interested in articles examining the molecular pathways involved in the induction of genomic instability in chronic inflammatory conditions; the role of the innate and adaptive inflammatory compartment in genomic instability and cancer progression; current concepts on how the immune system can be exploited for cancer therapy focusing on ongoing preclinical and clinical studies. Potential topics include, but are not limited to:

  • Preclinical and clinical studies using reagents that target components of the immune system in cancer therapy
  • Studies with mouse models examining the effect of the immune system in cancer development
  • Advances in biomarkers/prognostic factors of the immune system related with anti-tumor- or tumor-promoting activity
  • Molecular pathways implicated in the induction of genomic instability in chronic inflammatory conditions
  • Innate versus adaptive immunity and genomic instability

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jbb/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.